FDA panel recommends OTC status for second-generation antihistamines.
Rollins
G
G
D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D017336:Loratadine / Q000627:therapeutic use*; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D006634:Histamine H1 Antagonists; D004366:Nonprescription Drugs; D017336:Loratadine